In a recent review, it has been noted that hRR is a useful biomarker in cancer therapy similar to BRCA1 [115], and recent data has shown that hRR1 expression can be used as a useful biomarker for the selection of agents active in the treatment of cancer. This evidence concerns the gene BRCA1 and cancer.